ATLANTA, May 10, 2013 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company") today announced its financial results for the three month period ended March 31, 2013, and provided an update on recent corporate developments.

ATLANTA, May 6, 2013 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) ("Biota" or the "Company"), a biopharmaceutical company focused on the discovery and development of anti-infective products to prevent and treat serious and ...

These stocks are Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), Cell Therapeutics Inc (NASDAQ:CTIC), NeoStem Inc (NYSEAMEX:NBS), and Biota Pharmaceuticals Inc (NASDAQ:BOTA). This group of stocks are in the biotechnology industry and their market ...

Dunsire was a symbol of Takeda's transformation into a global pharma company, and she became the first female board member of Takeda after the company bought Millennium. Protopapas was formerly the business development chief at at the company. More ...

With labs in both the IWK and the QEII Health Sciences Centre, BIOTIC will be working with researchers and companies to support investigations and the commercialization of new life sciences products, and creating its own innovative medical technologies ...

Biota Pharmaceuticals Inc. adopted a revised corporate strategy following the recent completion of management's strategic and operational review of the organization and its various development programs.

Allecra is a strategic partnership between the company's founders including Nicholas Benedict, CEO of Allecra working in conjunction with Orchid Chemicals & Pharmaceuticals Limited (Chennai, India). Bacterial resistance to current antibiotics is ...